The Physiopathology Behind Valve Degeneration in TAVR

The degeneration of transcatheter biological valves clearly depends on time and starts with thrombus generation and subsequent histological changes resulting in valve failure (due to regurgitation, stenosis, or both).

La enfermedad vascular periférica se asocia a más eventos en el TAVIThrombus formation is the first change, observed early in computerized tomography (CT) scans after implantation. Most times it is completely asymptomatic, which leaves many of us wondering whether we should actually do something about this phenomenon.

 

This study provides more data and tells us that, perhaps, thrombus formation is just the beginning of a series of consecutive events over time such as endothelial hyperplasia, fibrosis, tissue remodeling, proteinase expression, and, ultimately, calcification.

 

This is the first study to investigate processes causing leaflet thickening and structural degeneration of transcatheter valves.


Read also: Bundle Branch Block and Need for Permanent Pacemaker, a Major Challenge after TAVR.


A few alarms went off with the first CT imaging studies showing thrombus formation and thickening. Based on those studies, this work provides histological details to better understand this phenomenon.

 

Researchers studied 23 explanted valves from 22 patients, from 0 to 2583 days after the procedure. Maximal leaflet thickness increased relative to implant duration (p = 0.027). Valves explanted after 2 years were thicker than those with shorter duration (p = 0.0027). All valves had adherent thrombi on both aortic and ventricular sides, which after 60 days combined with fibrosis and after 4 years, with calcification.

 

Early thrombus formation (<60 days after the procedure) occurred despite rapid endothelialization and was associated with an abnormal hyperplastic phenotype. Fibrosis was observed in 6 patients on both the aortic and the ventricular surfaces, and remodeled over time. All these changes were associated with matrix metalloproteinase-1 expression.


Read also: TAVR Is Feasible and Offers Good Outcomes in Patients with Cancer.


Five patients showed calcification, always associated with adherent thrombus and fibrosis.

 

Conclusion

Percutaneous valves degenerate over time. Such process seems to begin with thrombus formation and, after several evolution steps, results in calcification. Future investigations are needed to further understand these phenomena contributing to leaflet thickening and ulterior degeneration, and, above all, to try and prevent it, thus prolonging device duration. So far, the key seems to be taking measures during the earliest stage, the formation of adherent thrombi.

 

Original title: Transcatheter Aortic Heart Valves. Histological Analysis Providing Insight to Leaflet Thickening and Structural Valve Degeneration.

Reference: Stephanie L. Sellers et al. J Am Coll Cardiol Img 2019. Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Su opinión nos interesa. Puede dejar su comentario, reflexión, pregunta o lo que desee aquí abajo. Será más que bienvenido.

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...